ClinicalTrials.gov record
Recruiting Phase 3 Interventional

A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy

ClinicalTrials.gov ID: NCT03394365

Public ClinicalTrials.gov record NCT03394365. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 4, 2026, 4:19 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Multicenter, Open-Label, Phase 3 Study of Tabelecleucel for Solid Organ or Allogeneic Hematopoietic Cell Transplant Subjects With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure of Rituximab or Rituximab and Chemotherapy

Study identification

NCT ID
NCT03394365
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pierre Fabre Medicament
Industry
Enrollment
115 participants

Conditions and interventions

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 28, 2017
Primary completion
May 30, 2030
Completion
Jul 31, 2030
Last update posted
Feb 19, 2026

2017 – 2030

United States locations

U.S. sites
40
U.S. states
18
U.S. cities
31
Facility City State ZIP Site status
City of Hope (Adults and Pediatrics) Duarte California 91010 Completed
University of California San Diego Moores Cancer Center (Adults only) La Jolla California 92093 Completed
Loma Linda University Medical Center (Adults only) Loma Linda California 92354 Recruiting
Children's Hospital Los Angeles, Div. of Research Immunology/BMT (Adults and Pediatrics) Los Angeles California 90027 Recruiting
UCLA Medical Center (Adults and Pediatrics) Los Angeles California 90095 Completed
University of California Davis Comprehensive Cancer Center (Adults only) Sacramento California 95817 Completed
Yale University (Adults and Pediatrics) New Haven Connecticut 06519 Completed
MedStar Georgetown University Hospital (Adults and Pediatrics) Washington D.C. District of Columbia 20007 Recruiting
University of Florida (Adults and Pediatrics) Gainesville Florida 32610 Completed
University of Miami/Jackson Memorial Hospital (Adults only) Miami Florida 33136 Recruiting
Winship Cancer Institute (Adults only) Atlanta Georgia 30322 Completed
Arthur M. Blank Hospital (Pediatrics) Atlanta Georgia 30329 Recruiting
Ann & Robert H. Lurie Children's Hospital of Chicago (Adults and Pediatrics) Chicago Illinois 60611 Recruiting
University of Chicago Medical Center - Duchossois Center for Advanced Medicine (Adults only) Chicago Illinois 60637 Completed
Loyola University Medical Center (Adults and Pediatrics) Maywood Illinois 60153 Recruiting
University of Maryland School of Medicine (Adults only) Baltimore Maryland 21201 Completed
Dana Farber Cancer Institute, Brigham and Women's Hospital (Adults and Pediatrics) Boston Massachusetts 02215 Recruiting
Washington University School of Medicine (Adults only) St Louis Missouri 63110 Recruiting
Weill Cornell Medicine (Adults only) New York New York 10021 Completed
Columbia University Medical Center (Adults and Pediatrics) New York New York 10032 Completed
Memorial Sloan Kettering Cancer Center (Adults and Pediatrics) New York New York 10065 Completed
Montefiore Medical Center (Adults only) The Bronx New York 10467 Completed
Montefiore Medical Center (Pediatrics only) The Bronx New York 10467 Completed
University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center (Adults and Pediatrics) Chapel Hill North Carolina 27599 Completed
Carolinas Medical Center/Levine Children's Hospital (Adults and Pediatrics) Charlotte North Carolina 28204 Recruiting
Duke Cancer Institute (Adults and Pediatrics) Durham North Carolina 27710 Recruiting
Cleveland Clinic Foundation (Adults and Pediatrics) Cleveland Ohio 44195 Recruiting
Nationwide Children's Hospital (Pediatrics only) Columbus Ohio 43205 Completed
Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (Adults and Pediatrics) Columbus Ohio 43210 Recruiting
Oregon Health and Science University Physicians Pavilion (Adults and Pediatrics) Portland Oregon 97239 Recruiting
Hospital of the University of Pennsylvania (Adults only) Philadelphia Pennsylvania 19104 Recruiting
The Children's Hospital of Philadelphia Oncology Division, Blood & Marrow Transplant Section (Pediatrics) Philadelphia Pennsylvania 19104 Recruiting
University of Pittsburgh Medical Center (Adults only) Pittsburgh Pennsylvania 15232 Completed
Medical University of South Carolina (Adults and Pediatrics) Charleston South Carolina 29425 Active, not recruiting
Saint Jude Children's Research Hospital (Pediatrics only) Memphis Tennessee 38105 Completed
Vanderbilt University Medical Center Henry-Joyce Cancer Clinic (Adults and Pediatrics) Nashville Tennessee 37232 Recruiting
Baylor Scott and White Research Institute (Adults only) Dallas Texas 75246 Recruiting
University of Texas Southwestern Medical Center - Children's Medical Center (Pediatrics only) Dallas Texas 75390 Recruiting
MD Anderson Cancer Center (Pediatrics and Adult) Houston Texas 77030 Recruiting
Froedtert and Medical College of Wisconsin - Clinical Cancer Center (Adults only) Milwaukee Wisconsin 53226 Completed

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 31 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03394365, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 19, 2026 · Synced May 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03394365 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →